Selected data models

You must log in to select data models for download or further analysis.

52 Search results.
Relevance Rating New first Old first

Sepsis Case Report Form MEDUSA project - SAPS II- Score Report Form

- 11/17/20 - 1 form, 2 itemgroups, 8 items, 1 language
Itemgroups: Header module, SAPS II- Score
The MEDUSA project (medical education for sepsis source control and antibiotics) is a scientific study of the integrated research and treatment center "Center for Sepsis Control and Care" (CSCC) of the University Hospital Jena, Thuringia, Germany. Its aim is to investigate whether a multimodal and interdisciplinary training concept for the early recognition and standardized treatment of patients with sepsis improves time to administration of first antibiotic and survival of patients. Original forms obtained from: http://www.medusa.uniklinikum-jena.de/Datenerfassung.html

MEDUSA project - Sepsis treatment associated data report form

- 7/20/16 - 1 form, 5 itemgroups, 20 items, 1 language
Itemgroups: Header module, Lab results within the 24 hours of treatment, Antibiotic therapy, Previous antibiotic therapy?, Blood culture
The MEDUSA project (medical education for sepsis source control and antibiotics) is a scientific study of the integrated research and treatment center "Center for Sepsis Control and Care" (CSCC) of the University Hospital Jena, Thuringia, Germany. Its aim is to investigate whether a multimodal and interdisciplinary training concept for the early recognition and standardized treatment of patients with sepsis improves time to administration of first antibiotic and survival of patients. Original forms obtained from: http://www.medusa.uniklinikum-jena.de/Datenerfassung.html

dbGaP phs000631 ARDSnet and the iSPAAR Consortium: Genetic Studies - Eligibility

- 11/23/22 - 6 forms, 1 itemgroup, 12 items, 1 language
Itemgroup: IG.elig
Principal Investigator: Mark M. Wurfel, MD, PhD, University of Washington, Seattle, WA, USA MeSH: Respiration Disorders,Sepsis https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000631 Acute Respiratory Distress Syndrome (ARDS)/ Acute Lung Injury (ALI) is a syndrome defined by the presence of acute hypoxemic respiratory failure, bilateral pulmonary infiltrates on chest radiograph, a known clinical risk factor (e.g. sepsis, pneumonia, trauma, gastric fluid aspiration, pancreatitis, massive transfusion), and the absence of physiologic or clinical evidence of congestive heart failure. The Identification of SNPs Predisposing to Altered ALI Risk (iSPAAR) study is a multi-institutional cooperative study, funded through the NHLBI Recovery Act, that assembled samples and phenotype information from existing cohorts. The consortium included samples from patients with ARDS from the NIH NHLBI ARDS Clinical Trials Network (ARDSNet). Samples were obtained from 3 interventional treatment trials in patients with ARDS, including the Fluid and Catheter Treatment Trial (FACTT), the Albuterol to Treat Acute Lung Injury (ALTA) trial, and the Omega-3 Fatty Acid/Antioxidant Supplementation for ALI trial (Omega). In addition to ARDSnet samples, samples from the other cohorts included cases of established ARDS but also controls: critically ill patients who were at-risk for ARDS but who did not develop ARDS during their hospital course. These cohorts included the Molecular Epidemiology of Acute Respiratory Distress (MEA) Study enrolled at the Harvard University/Massachusetts General Hospital, the Systemic Inflammatory Immune Response Syndrome (SIRS) Patient Database and ICU Traumatic Injury cohorts from Harborview Medical Center, and cohorts collected from the ALI research programs at the University of Pennsylvania and the University of California, San Francisco. *The Cohort is utilized in the following dbGaP sub-studies.* To view genotypes, other molecular data, and derived variables collected in these sub-studies, please click on the following sub-studies below or in the "Sub-studies" box located on the right hand side of this top-level study page phs000631 ARDSnet iSPAAR Consortium.- phs000334 ESP_LungGO_ALI - phs000686 ALI_GeneticRisk

pht003599.v1.p1

1 itemgroup 3 items

pht003600.v1.p1

1 itemgroup 4 items

pht003601.v1.p1

1 itemgroup 15 items

pht003602.v1.p1

1 itemgroup 5 items

pht003603.v1.p1

1 itemgroup 5 items

(1,3)-ß-D-Glucan CandiSep Anesthesiology and Intensive Care NCT02734550 - (1,3)-ß-D-Glucan

- 9/20/21 - 1 form, 2 itemgroups, 11 items, 1 language
Itemgroups: beta-1,3-D-glucan, beta-1,3-D-glucan day 1
Study part: (1,3)-ß-D-Glucan. (1,3)-β-D-glucan-based diagnosis of invasive Candida infection versus culture-based diagnosis in patients with severe sepsis or septic shock and at high risk of invasive Candida infection (CandiSep). Provided by PD Dr. med. Frank Bloos, Ph.D. Clinic for Anesthesiology and Intensive care, University Clinic Jena.

Demography Screening CandiSep Anesthesiology and Intensive Care NCT02734550 - Demography Screening

- 9/20/21 - 1 form, 1 itemgroup, 11 items, 1 language
Itemgroup: Demography
Study part: Demography Screening. (1,3)-β-D-glucan-based diagnosis of invasive Candida infection versus culture-based diagnosis in patients with severe sepsis or septic shock and at high risk of invasive Candida infection (CandiSep). Provided by PD Dr. med. Frank Bloos, Ph.D. Clinic for Anesthesiology and Intensive care, University Clinic Jena.

Consent Screening CandiSep Anesthesiology and Intensive Care NCT02734550 - Consent Screening

- 9/20/21 - 1 form, 1 itemgroup, 16 items, 1 language
Itemgroup: Consent
Study part: Consent Screening. (1,3)-β-D-glucan-based diagnosis of invasive Candida infection versus culture-based diagnosis in patients with severe sepsis or septic shock and at high risk of invasive Candida infection (CandiSep). Provided by PD Dr. med. Frank Bloos, Ph.D. Clinic for Anesthesiology and Intensive care, University Clinic Jena.

Randomization CandiSep Anesthesiology and Intensive Care NCT02734550 - Randomization

- 9/20/21 - 1 form, 1 itemgroup, 5 items, 1 language
Itemgroup: Randomization
Study part: Randomization. (1,3)-β-D-glucan-based diagnosis of invasive Candida infection versus culture-based diagnosis in patients with severe sepsis or septic shock and at high risk of invasive Candida infection (CandiSep). Provided by PD Dr. med. Frank Bloos, Ph.D. Clinic for Anesthesiology and Intensive care, University Clinic Jena.

Patient status Hospital discharge CandiSep Anesthesiology and Intensive Care NCT02734550 - Patient status Hospital discharge

- 9/20/21 - 1 form, 1 itemgroup, 8 items, 1 language
Itemgroup: Patient status
Study part: Patient status Hospital discharge. (1,3)-β-D-glucan-based diagnosis of invasive Candida infection versus culture-based diagnosis in patients with severe sepsis or septic shock and at high risk of invasive Candida infection (CandiSep). Provided by PD Dr. med. Frank Bloos, Ph.D. Clinic for Anesthesiology and Intensive care, University Clinic Jena.

Patient status Day 28 CandiSep Anesthesiology and Intensive Care NCT02734550 - Patient status Day 28

- 9/20/21 - 1 form, 2 itemgroups, 19 items, 1 language
Itemgroups: Patient status, Admission to intensive care unit
Study part: Patient status Day 28. (1,3)-β-D-glucan-based diagnosis of invasive Candida infection versus culture-based diagnosis in patients with severe sepsis or septic shock and at high risk of invasive Candida infection (CandiSep). Provided by PD Dr. med. Frank Bloos, Ph.D. Clinic for Anesthesiology and Intensive care, University Clinic Jena.

MEDUSA Anesthesiology and Intensive Care NCT01187134 - MEDUSA Anesthesiology and Intensive Care

- 9/20/21 - 1 form, 15 itemgroups, 139 items, 1 language
Itemgroups: General information, Sepsis, Sepsis-associated organ dysfunction, Exclusion criteria, clinic parameters, Laboratory Parameters, antimicrobial therapy, Antibiotic therapy, blood culture, discharge, therapy course, health status, intensive care unit discharge, hospital discharge, SAPS II
NCT01187134 Medical Education for Sepsis Source Control and Antibiotics (MEDUSA). Provided by PD Dr. med. Frank Bloos, Ph.D. Clinic for Anesthesiology and Intensive care, University Clinic Jena.

Eligibility NCT00832039 Severe Sepsis - Eligibility

- 9/20/21 - 1 form, 2 itemgroups, 15 items, 2 languages
Itemgroups: Inclusion Criteria, Exclusion Criteria
ODM derived from http://clinicaltrials.gov/show/NCT00832039

Eligibility NCT00534287 Severe Sepsis - Eligibility

- 9/20/21 - 1 form, 2 itemgroups, 27 items, 2 languages
Itemgroups: Inclusion Criteria, Exclusion Criteria
ODM derived from http://clinicaltrials.gov/show/NCT00534287

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial